semaglutide death The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications Ozempic Slows Kidney Disease, Novo

Microdosing approaches with slower escalation can reduce the sleep impact of dose transitions

esto implica que no todos experimentarn beneficios similares con su uso regular

Our recent studies reported that sodium butyrate (NaB) reduced high-fat diet (HFD)-induced gut microbiota dysbiosis and endotoxemia 10 and prevented HFD-induced steatohepatitis by modulating the immune response in the gut and liver 11

Split across the week: Optional

The New York-based startup says it also works with health systems to connect patients with additional obesity care like bariatric surgery or specialty care for chronic conditions like diabetes that are often comorbid with obesity